Tyndall Capital Partners L P - Net Worth and Insider Trading
Tyndall Capital Partners L P Net Worth
The estimated net worth of Tyndall Capital Partners L P is at least $25,506 dollars as of 2024-05-27. Tyndall Capital Partners L P is the 10% Owner of Traws Pharma Inc and owns about 41,093 shares of Traws Pharma Inc (TRAW) stock worth over $25,506. Details can be seen in Tyndall Capital Partners L P's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Tyndall Capital Partners L P has not made any transactions after 2019-09-24 and currently still holds the listed stock(s).
Transaction Summary of Tyndall Capital Partners L P
Tyndall Capital Partners L P Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Tyndall Capital Partners L P owns 1 companies in total, including Traws Pharma Inc (TRAW) .
Click here to see the complete history of Tyndall Capital Partners L P’s form 4 insider trades.
Insider Ownership Summary of Tyndall Capital Partners L P
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TRAW | Traws Pharma Inc | 2019-09-24 | 10 percent owner |
Tyndall Capital Partners L P Latest Holdings Summary
Tyndall Capital Partners L P currently owns a total of 1 stock. Tyndall Capital Partners L P owns 41,093 shares of Traws Pharma Inc (TRAW) as of September 24, 2019, with a value of $25,506.
Latest Holdings of Tyndall Capital Partners L P
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TRAW | Traws Pharma Inc | 2019-09-24 | 41,093 | 0.62 | 25,506 |
Holding Weightings of Tyndall Capital Partners L P
Tyndall Capital Partners L P Form 4 Trading Tracker
According to the SEC Form 4 filings, Tyndall Capital Partners L P has made a total of 9 transactions in Traws Pharma Inc (TRAW) over the past 5 years, including 0 buys and 9 sells. The most-recent trade in Traws Pharma Inc is the sale of 1,113 shares on September 24, 2019, which brought Tyndall Capital Partners L P around $19,873.
Insider Trading History of Tyndall Capital Partners L P
- 1
Tyndall Capital Partners L P Trading Performance
GuruFocus tracks the stock performance after each of Tyndall Capital Partners L P's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Tyndall Capital Partners L P is -25.45%. GuruFocus also compares Tyndall Capital Partners L P's trading performance to market benchmark return within the same time period. The performance of stocks bought by Tyndall Capital Partners L P within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Tyndall Capital Partners L P's insider trading performs compared to the benchmark.
Performance of Tyndall Capital Partners L P
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -3.75 | | | | | |
| Relative Return to S&P 500(%) | -5.68 | | | | | |
Tyndall Capital Partners L P Ownership Network
Tyndall Capital Partners L P Owned Company Details
What does Traws Pharma Inc do?
Who are the key executives at Traws Pharma Inc?
Tyndall Capital Partners L P is the 10 percent owner of Traws Pharma Inc. Other key executives at Traws Pharma Inc include CHIEF MEDICAL OFFICER Victor M Moyo , VP Corp Dev & Gen Counsel Abraham N. Oler , and Chief Medical Officer Steven M Fruchtman .
Traws Pharma Inc (TRAW) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Traws Pharma Inc (TRAW) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Traws Pharma Inc (TRAW) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Traws Pharma Inc (TRAW)'s detailed insider trading history can be found in Insider Trading Tracker table.
Traws Pharma Inc Insider Transactions
Tyndall Capital Partners L P Mailing Address
Above is the net worth, insider trading, and ownership report for Tyndall Capital Partners L P. You might contact Tyndall Capital Partners L P via mailing address: 150 East 58th Street, 14th Floor, New York Ny 10155.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
